35 results on '"Nunanan, Pongjarat"'
Search Results
2. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial
3. Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
4. Tu1623 COMPARATIVE EFFICACY OF ENCAPSULATED FECAL MICROBIOTA TRANSPLANTATION (FMT) AND FMT VIA RECTAL ENEMA FOR IRRITABLE BOWEL SYNDROME (IBS): A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY (CAP-ENEMA FMT TRIAL)
5. Tu1081: IMPROVED ERADICATION RATE OF STANDARD TRIPLE THERAPY BY ADDING PROBIOTIC SUPPLEMENT FOR H.PYLORI TREATMENT IN AREA OF HIGH CLARITHROMYCIN RESISTANCE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
6. Tu1076: NATIONWIDE STUDY OF PREVALENCE RATES AND ANTIBIOTIC RESISTANT PATTERNS OF H. PYLORI INFECTION IN THAILAND COMPARING TO ASEAN COUNTRIES
7. Tu1368: EFFECT OF FECAL MICROBIOTA TRANSPLANTATION (FMT) ON IRRITABLE BOWEL SYNDROME (IBS): A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
8. Tu1070: HIGH EFFICACY OF 14-DAY VONOPRAZAN-BASED QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREAS WITH HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY (VQ-HP TRIAL)
9. Tu1075: PILOT STUDIES OF VONOPRAZAN-CONTAINING HELICOBACTER PYLORI ERADICATION THERAPY SUGGEST THAILAND MAY BE MORE SIMILAR TO THE US THAN JAPAN
10. Tu1079: PREDICTIVE FACTORS FOR SUCCESSFUL ERADICATION IN PATIENTS WITH HELICOBACTER PYLORI TREATMENT FAILURES: A LARGE POPULATION-BASED STUDY
11. 685 THE EFFICACY OF 12-WEEK SUPERVISED HOME-BASED EXERCISE AND BRANCHED-CHAIN AMINO ACIDS SUPPLEMENTATION FOR TREATMENT OF SARCOPENIA IN CIRRHOTIC PATIENTS: A PROSPECTIVE PILOT STUDY.
12. Tu1920 FECAL MICROBIOTA TRANSPLANT ENEMA AS A PROMISING TREATMENT IN METABOLIC SYNDROME: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
13. Tu1919 IMPROVEMENT OF INSULIN RESISTANCE FOLLOWING FECAL MICROBIOTA TRANSPLANTATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
14. Tu1644 LONG-TERM EFFICACY AND SAFETY OF ENCAPSULATED FECAL MICROBIOTA TRANSPLANTATION (FMT) AND FMT VIA RECTAL ENEMA FOR IRRITABLE BOWEL SYNDROME (IBS): A PROSPECTIVE COHORT STUDY
15. Mo1924 EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN IRRITABLE BOWEL SYNDROME: UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
16. Mo1920 EFFICACY OF VONOPRAZAN TRIPLE THERAPY COMBINED WITH ENCAPSULATED FECAL MICROBIOTA TRANSPLANTATION (FMT) AS ADJUVANT FOR HELICOBACTER PYLORI ERADICATION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY (FMT-HP TRIAL)
17. Sa1375 EPIDEMIOLOGY AND ANTIBIOTIC RESISTANCE PATTERN OF HELICOBACTER PYLORI INFECTION IN SOUTH EAST ASIA COUNTRIES: A SYSTEMATIC REVIEW WITH META-ANALYSIS
18. Sa1373 EXCELLENT ERADICATION RATE OF ONCE-DAILY VONOPRAZAN LEVOFLOXACIN-BASED QUADRUPLE THERAPY FOR H. PYLORI INFECTION IN HIGH CLARITHROMYCIN RESISTANCE AREA: A PROSPECTIVE RANDOMIZED STUDY (ONCE-VONO TRIAL)
19. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial)
20. PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED GASTRIC CANCER: A LONGITUDINAL POPULATION-BASED STUDY.
21. ID: 3522949 ACCURACY OF HELICOBACTER PYLORI DETECTION UNDER WHITE LIGHT AND IMAGE-ENHANCED ENDOSCOPY (IEE): A PROSPECTIVE RANDOMIZED STUDY
22. ID: 3523289 PREDICTORS FOR REGRESSION AND PROGRESSION OF INTESTINAL METAPLASIA (IM): A LARGE POPULATION-BASED STUDY FROM LOW PREVALENCE AREA OF GASTRIC CANCER (IM-PREDICTOR TRIAL)
23. Su349 THE IMPACT OF FRAILTY ON DECOMPENSATION AND SURVIVAL IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE COHORT STUDY
24. SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF GASTRIC OUTLET OBSTRUCTION IN GASTRIC CANCER PATIENTS IN ASIA: A LARGE POPULATION-BASED STUDY (GGC-ASIA TRIAL)
25. PREDICTIVE FACTORS ASSOCIATED WITH OVERALL SURVIVAL RATE IN FEMALE GASTRIC CANCER PATIENTS: A LARGE POPULATION-BASED STUDY IN THE ASSOCIATION OF SOUTHEAST ASIAN NATIONS (FGC-ASEAN TRIAL)
26. PREVALENCE OF GASTRIC CANCER AND GASTRIC PRECANCEROUS LESIONS RELATED TO HELICOBACTER PYLORI INFECTION: A REAL-WORLD EVIDENCE-ACCESS FROM TERTIARY CARE CENTER STUDY (PGC-HP TRIAL)
27. 270 COST-EFFECTIVENESS ANALYSIS OF ANTIBIOTIC SUSCEPTIBILITY TESTING (AST) IN PATIENTS WITH HELICOBACTER PYLORI TREATMENT FAILURE: A LARGE POPULATION-BASED STUDY (COST-EFF-HP TRIAL)
28. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial)
29. Gastrointestinal manifestation as clinical predictor of severe COVID ‐19: A retrospective experience and literature review of COVID ‐19 in Association of Southeast Asian Nations ( ASEAN)
30. Tu1508 PREDICTORS FOR DEVELOPMENT OF COMPLETE AND INCOMPLETE INTESTINAL METAPLASIA (IM) ASSOCIATED WITH HELICOBACTER PYLORI INFECTION: A LARGE-SCALE STUDY FROM LOW PREVALENCE AREA OF GASTRIC CANCER (IM-HP TRIAL)
31. Su1382 INEFFECTIVENESS OF 14-DAY VONOPRAZAN-BASED DUAL THERAPY AND VONOPRAZAN-BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREA OF HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY
32. Tu1697 ASSOCIATION BETWEEN FRAILTY STATUS AND QUALITY OF LIFE IN COMPENSATED CIRRHOTIC PATIENT
33. Gastrointestinal Manifestation as Clinical Predictor of Severe COVID-19: A Retrospective Experience and Literature Review of COVID-19 in ASEAN
34. OPTIMIZED ENDOSCOPIC SURVEILLANCE INTERVALS FOR DETECTING PROGRESSION OF INTESTINAL METAPLASIA (IM): A LARGE POPULATION-BASED STUDY FROM LOW PREVALENCE AREA OF GASTRIC CANCER (IM-SURVEILLANCE TRIAL).
35. Tu1595 Grave Prognosis of Esophageal Cancer in Thailand
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.